Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of MECP2 mRNA | increases expression | 18648102
|
C075773 |
4-phenylbutyric acid |
[4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein | affects acetylation|affects expression | 18497984
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MECP2 mRNA | affects expression | 17562736
|
D006710 |
Homocysteine |
decitabine inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
D006710 |
Homocysteine |
decitabine inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
D006710 |
Homocysteine |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
D006710 |
Homocysteine |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
D006710 |
Homocysteine |
Homocysteine inhibits the reaction [MECP2 protein binds to CCNA1 promoter] | affects binding|decreases reaction | 17698632
|
D006710 |
Homocysteine |
trichostatin A inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
D006710 |
Homocysteine |
trichostatin A inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MECP2 mRNA | affects expression | 16483693
|
D001374 |
Azacitidine |
Azacitidine inhibits the reaction [MECP2 protein binds to CCNA1 promoter] | affects binding|decreases reaction | 17698632
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 18164116
|
D001761 |
Bleomycin |
MECP2 protein affects the susceptibility to Bleomycin | affects response to substance | 21435439
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MECP2 mRNA | decreases expression | 15336504
|
D002087 |
Butyrates |
Butyrates inhibits the reaction [MECP2 protein binds to CCNA1 promoter] | affects binding|decreases reaction | 17698632
|
D002087 |
Butyrates |
Butyrates results in decreased expression of MECP2 mRNA | decreases expression | 16042588
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MECP2 mRNA | affects expression | 17484886
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 18636392
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 17891453
|
C014347 |
decitabine |
decitabine inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
C014347 |
decitabine |
decitabine inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 18164116
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of MECP2 mRNA | decreases expression | 18035473
|
D005492 |
Folic Acid |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
D005492 |
Folic Acid |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
D019833 |
Genistein |
Genistein results in increased expression of MECP2 mRNA | increases expression | 15256057
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of MECP2 protein mutant form | increases expression | 19190538
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 18636392
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MECP2 mRNA | increases expression | 19822182
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in decreased expression of MECP2 mRNA | affects cotreatment|decreases expression | 17891453
|
C012589 |
trichostatin A |
trichostatin A inhibits the reaction [Homocysteine results in decreased expression of MECP2 mRNA] | decreases expression|decreases reaction | 18310117
|
C012589 |
trichostatin A |
trichostatin A inhibits the reaction [Homocysteine results in decreased expression of MECP2 protein] | decreases expression|decreases reaction | 18310117
|
C012589 |
trichostatin A |
trichostatin A inhibits the reaction [MECP2 protein binds to CCNA1 promoter] | affects binding|decreases reaction | 17698632
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
8.94 | 16595132 16316344 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
8.94 | 11274264 |
MESH:D055371 |
Acute Lung Injury |
|
Bleomycin |
9.45 | 17118201 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
9.45 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.45 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
15.52 | 3712494 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
15.52 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
15.52 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
15.52 | 16963246 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.79 | 19061943 16434500 17620307 17162532 19052882 18056438 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.59 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.80 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
4.48 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.48 | 15513908 |
MESH:D017204 |
Angelman Syndrome |
marker/mechanism |
|
| |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D000860 |
Anoxia |
|
Bleomycin |
5.30 | 15782499 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.53 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.60 | 17854713 16373670 |
OMIM:300496 |
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3 |
marker/mechanism |
|
| |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15211631 18621663 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.34 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.34 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
2.34 | 16297937 20468076 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 1440618 11289319 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.02 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
2.02 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.02 | 17200150 16541309 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.59 | 17626835 18417511 19059883 18315731 15516495 14754758 16777450 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.63 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.67 | 15673190 18705752 16227642 16011737 15700767 16192424 15721981 16124888 16050911 3786805 16097048 10355542 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
11.16 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.16 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.16 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.16 | 20084675 19919837 20007298 16328049 16698587 17055752 19383236 19208518 19107877 16935385 19822196 20727157 16540662 19701751 19171122 3084413 19539802 16681979 17428255 18506893 21159647 16502159 20935162 20432363 18494052 10672840 17162532 16878318 16830150 19418558 18785209 18210153 20524982 18056438 18978308 16288022 16807293 10737359 20512989 17173139 17138121 18788625 17978847 19052882 11831363 16569478 20101231 17761372 19519916 18691550 16779866 20214788 19394651 20514400 19335982 18971187 3581430 18393292 18665156 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
11.16 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.16 | 17306315 15276417 16507464 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.62 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Bleomycin |
7.57 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.57 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.57 | 18572023 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
7.43 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.43 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.52 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.77 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.77 | 17174075 7505956 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.77 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.59 | 19052882 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.06 | 9022650 19486331 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.92 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
3.52 | 21254359 8946559 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
5.88 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.88 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.88 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.63 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.63 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
3.63 | 16985020 17087956 17116713 16963246 17245555 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.72 | 16379339 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 19559301 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.70 | 11906362 8156756 2524372 14531868 8970840 18759878 11298694 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.39 | 3621924 2952479 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 19559301 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
7.14 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
7.14 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.14 | 16647724 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.70 | 16192314 6679447 7440962 9653073 18692083 8291058 18289764 1440618 9328219 9022650 11289319 18648102 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.70 | 11739529 16177239 19923254 12594235 16781746 19085960 10774834 15968718 16393943 12705907 2444490 17522070 10663392 11421492 11743745 11834606 19420014 14986274 12540782 16227642 15619225 17906064 12153990 19164858 19370779 12958197 14550746 16109766 19416960 11287661 12392966 10915739 18713872 16081117 11529661 18071297 17562736 19739265 14725611 16485898 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.70 | 9327722 15968718 19085960 19336974 17522070 7120509 7179309 15998439 21278145 3732212 16177239 3786805 4309450 10092053 2869522 6884620 7440962 6623471 16227642 11566570 15027814 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.70 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
4.36 | 11033412 15033597 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.52 | 20016425 |
MESH:D004487 |
Edema |
|
Bleomycin |
4.15 | 17118201 |
OMIM:300673 |
ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS |
marker/mechanism |
|
| |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.68 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.68 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.48 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
7.65 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.65 | 11473722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.01 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.08 | 3581430 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
13.03 | 16504073 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
13.03 | 16504073 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.49 | 16239168 12631006 16045604 12795759 19224547 61145 15959796 17595544 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
7.49 | 21071580 20387270 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.35 | 18705752 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.90 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
10.92 | 16983495 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
10.92 | 17171786 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.57 | 16452187 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
11.50 | 16504073 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
11.50 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.27 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.27 | 18801729 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.41 | 19215824 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
4.79 | 17868369 19130971 15968427 18024279 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
7.29 | 16524890 17286298 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
7.29 | 19638421 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.87 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.87 | 19900420 19110552 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.38 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Bleomycin |
7.52 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.52 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.61 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.42 | 16899240 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.60 | 17652376 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
9.52 | 16395265 16755160 16433478 16397167 16865747 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
9.52 | 17369066 18234410 17292331 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.98 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.66 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.66 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Bleomycin |
8.23 | 17118201 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.23 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.23 | 17296493 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 9022650 8074119 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
5.62 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.84 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
9.84 | 18289764 19349640 17934191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.84 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.88 | 6582329 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
5.28 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.37 | 10219319 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
10.34 | 19148494 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.34 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
10.34 | 17468513 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
9.56 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.56 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.26 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.26 | 19387464 18460780 18206229 19010910 18704418 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.26 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.36 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.09 | 19299654 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.41 | 16239168 11903743 17157831 11408273 21278145 16943688 16221502 17334410 17174718 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.41 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.55 | 12958196 18395914 15650968 17557913 17721639 15673190 15893842 12445418 18429990 17922224 18279442 17823541 18263696 14512876 15959796 18251166 14724832 12546737 11481614 15931870 16097048 15876570 17869086 18376398 18472332 12632514 18420326 17805973 20821823 15925388 17976157 12667390 16011737 12389079 12741479 16015684 18277467 12898905 12586293 18156304 16136751 16248980 15123356 15818738 15362042 18472094 14748882 14716496 18339082 13678700 18205269 17714472 18481824 18006644 18166357 18210741 18395095 15338365 12609069 12666154 17481882 18054572 15052691 15730626 17900296 18412020 14716833 17698563 10355542 14620537 18705752 12445421 15057751 17525996 16116963 15370692 18317297 18418968 16027843 17708605 17944888 17640975 16033810 16638106 17565644 17761835 15996030 12649538 18187930 17631135 12632512 17766677 16192424 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
2.55 | 17823541 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
9.18 | 12969438 16610002 19784758 19014921 12587719 19460945 11587558 16611625 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
9.18 | 17285989 16246199 15830285 15720792 16964402 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
9.18 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
9.18 | 16877991 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.05 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.08 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.08 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
10.40 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.40 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.40 | 19073162 19254457 19690152 21278145 20583210 19638242 21167192 18648771 9163691 2422723 12771043 19551842 19833225 18644402 19255062 20101389 20434301 20118626 19996281 19426721 19850985 18978307 21047994 19294768 19256749 19812893 15885732 18754104 12112319 19499222 19427195 20452335 10737359 18977376 20492335 15175105 20137499 20501860 16942905 21071580 20405173 19090486 19642983 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.40 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
13.59 | 3712494 6587162 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
13.59 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.59 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.59 | 17942915 19004024 18253720 19009564 18093689 18775883 19519916 18544905 17854601 2563599 21159647 16267830 3124819 17174075 19126423 18079962 16842330 19539802 18164116 9362446 18282651 18308698 |
MESH:C537723 |
Lubs X-linked mental retardation syndrome |
marker/mechanism |
|
| |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.27 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.27 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.74 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
6.50 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Bleomycin |
6.50 | 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.50 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
6.50 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.50 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.31 | 17718048 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.34 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.87 | 14578162 12929590 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.58 | 16832597 |
MESH:D008545 |
Melanoma |
|
Bleomycin |
7.25 | 15577320 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.25 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.25 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.25 | 16505122 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
5.43 | 16602021 |
OMIM:300055 |
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13 |
marker/mechanism |
|
| |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.00 | 10496685 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.98 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
11.89 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.89 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.89 | 18172295 |
MESH:D009123 |
Muscle Hypotonia |
marker/mechanism |
|
| 19559301 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.17 | 18694830 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
7.61 | 19805378 17611569 18720364 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.61 | 16882708 18608210 19010910 19157545 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
6.10 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
6.10 | 17412321 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.58 | 17141266 |
MESH:D009207 |
Myoclonus |
marker/mechanism |
|
| 19559301 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.56 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.56 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
8.20 | 19116145 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.20 | 19116145 19470736 17925555 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.20 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.56 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
3.92 | 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.83 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
11.83 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.83 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.88 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.88 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.01 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
4.40 | 16322990 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.32 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.18 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.98 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.08 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.08 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.08 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.08 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.53 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.53 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
8.53 | 19294695 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.38 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
3.53 | 16275827 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.02 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Bleomycin |
11.05 | 18024389 17071938 16317386 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.05 | 18007984 18929643 18381685 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.46 | 2563599 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
12.06 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
12.06 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.19 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.19 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.19 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.19 | 18798265 19789329 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.62 | 15033597 |
MESH:D011654 |
Pulmonary Edema |
|
Bleomycin |
5.21 | 15808516 |
MESH:D011658 |
Pulmonary Fibrosis |
marker/mechanism |
|
| 21435439 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Bleomycin |
3.83 | 17434272 17241526 15322207 14609568 18162602 15541506 21435439 16314464 17177178 16115399 12624602 12574379 11554783 18008008 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
10.44 | 15728788 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
10.44 | 15728788 17132701 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.11 | 18579056 |
MESH:D012131 |
Respiratory Insufficiency |
marker/mechanism |
|
| 19559301 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.17 | 18644591 |
MESH:D015518 |
Rett Syndrome |
marker/mechanism |
|
| 19559301 21316312 19190538 17433737 19000991 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.30 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
4.21 | 16641680 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
4.21 | 16641680 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.22 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.66 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.66 | 8532709 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.38 | 16361298 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.71 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.46 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.46 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
3.46 | 17171786 |
MESH:D020521 |
Stroke |
|
Folic Acid |
4.24 | 16517955 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.46 | 3712494 1399818 6582329 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
16.46 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
16.46 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
16.46 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.12 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.12 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.12 | 16712894 11723127 17306315 16452187 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.67 | 11813266 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.81 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.32 | 17056641 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.41 | 18776599 |
MESH:D015431 |
Weight Loss |
|
Bleomycin |
5.53 | 12624602 |